Surgery Partners Welcomes Dr. Laura Forese to Its Board

Surgery Partners Welcomes Dr. Laura Forese to Its Board

Surgery Partners, Inc. (NASDAQ: SGRY), a notable healthcare services company with a market cap of $2.67 billion, recently announced an important addition to its Board of Directors. Dr. Laura L. Forese has joined the board, bringing extensive experience in healthcare administration and orthopedic surgery. This appointment has expanded the board to eleven members, signaling the company's commitment to enhancing its leadership structure.

Dr. Forese's Extensive Background in Healthcare

Dr. Forese comes with over 40 years of experience in healthcare executive roles. Her prior position as executive vice president and chief operating officer at a leading academic healthcare institution involved overseeing multiple hospital campuses and numerous clinics, managing a workforce of more than 45,000 employees. Dr. Forese’s efforts in establishing standardized practices at major healthcare organizations have proven invaluable, contributing to consistent patient care quality.

Focus on Patient Safety and Healthcare Transformation

Throughout her career, Dr. Forese has prioritized patient safety, operational efficiency, and system-level healthcare transformation. Her involvement with various healthcare and civic initiatives includes participation in boards that focus on clinical research and university governance, showcasing her dedication to advancing healthcare beyond her immediate roles.

Academic Accomplishments and Recognition

Dr. Forese holds a medical degree from Columbia University College of Physicians & Surgeons and a master's in health services management from the same institution. Her undergraduate study in civil engineering and operations research at Princeton University was marked by her graduation with highest honors, highlighting her strong academic foundation that complements her professional expertise.

Enhancing Surgery Partners' Operations

Wayne DeVeydt, Chairman of Surgery Partners' Board of Directors, expressed excitement regarding Dr. Forese’s addition to the board. He recognized her vast knowledge and enthusiasm for delivering high-quality healthcare operations, which aligns perfectly with Surgery Partners' strategic objectives, especially in the area of increasing short-stay surgical cases.

Growth and Expansion in the Surgical Services Sector

Surgery Partners, founded in 2004, has grown into one of the largest outpatient surgical service providers in the United States. With a presence in over 200 locations across 33 states, the company has demonstrated a solid growth trajectory, evidenced by a recent revenue increase of approximately 10% to $2.99 billion. This robust growth emphasizes the organization's successful strategies and operational efficiency.

Positive Market Indicators and Analyst Projections

The outlook for Surgery Partners remains positive, with analysts stressing their optimistic projections for profitability in the coming year. The company's recent performance metrics, including a 14% year-over-year increase in net revenue and a substantial rise in adjusted EBITDA, further validate the effectiveness of their operational strategies.

Resilience Amidst Challenges

Despite facing hurdles, including operational interruptions due to severe weather, Surgery Partners has managed to report a consistent increase in surgical case volumes and same-facility net revenues. The company’s commitment to recruitment has led to the onboarding of over 230 new physicians, indicating strong growth in service capacity.

Looking Ahead: Financial Projections

Surgery Partners forecasts robust financial outcomes for the full year, anticipating net revenue and adjusted EBITDA to surpass $3.075 billion and $508 million, respectively. This projection reflects the company’s proactive approach and commitment to maintaining its growth trajectory in the competitive healthcare market.

Frequently Asked Questions

Who is Dr. Laura Forese?

Dr. Laura Forese is a seasoned healthcare executive with over 40 years of experience in healthcare administration and orthopedic surgery, now serving on the board of Surgery Partners.

What role did Dr. Forese hold before joining Surgery Partners?

Before joining Surgery Partners, Dr. Forese was the executive vice president and chief operating officer at New York-Presbyterian, managing multiple hospital campuses and clinics.

How is Surgery Partners performing financially?

Surgery Partners recently reported a 14% increase in net revenue and a significant rise in adjusted EBITDA, indicating strong financial health and operational efficiency.

What is Surgery Partners' market capitalization?

The market capitalization of Surgery Partners is approximately $2.67 billion, reflecting its status as a major player in the healthcare services sector.

What are the future projections for Surgery Partners?

The company anticipates exceeding $3.075 billion in net revenue and $508 million in adjusted EBITDA for the full year, demonstrating strong growth expectations.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.